Barriers and Facilitators to the Choice of Active Surveillance for Low-Risk Papillary Thyroid Cancer in China: A Qualitative Study Examining Patient Perspectives

被引:13
|
作者
Zhu, Pingting [1 ,2 ]
Zhang, Qianqian [1 ,3 ]
Wu, Qiwei [1 ]
Shi, Guanghui [1 ]
Wang, Wen [1 ]
Xu, Huiwen [1 ]
Zhang, Li [4 ]
Qian, Meiyan [1 ]
Hegarty, Josephine [5 ]
机构
[1] Yangzhou Univ, Sch Nursing & Publ Hlth, Dept Nursing, 136 Jiangyang Middle Rd, Yangzhou 225009, Peoples R China
[2] Jiangsu Key Lab Zoonosis, Yangzhou, Peoples R China
[3] Nanjing Med Univ, Affiliated Hosp 1, Dept Anesthesia & Perioperat Med, Nanjing, Peoples R China
[4] Xuzhou Med Univ, Affiliated Hosp 1, Dept Gen Surg, Xuzhou, Peoples R China
[5] Univ Coll Cork, Dept Nursing & Midwifery, Brookfield Hlth Sci Complex, Cork T12 K8AF, Ireland
基金
中国国家自然科学基金;
关键词
papillary thyroid cancer; active surveillance; barriers; facilitators; qualitative study; INFORMATION NEEDS; MANAGEMENT; NODULES; SURGERY; SYSTEM;
D O I
10.1089/thy.2022.0347
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Internationally, several clinical practice guidelines recommend active surveillance as a nonsurgical management strategy for select patients with low-risk papillary thyroid carcinoma. However, patient's decision making when choosing active surveillance as a management approach is not well understood. Thus, our aim was to examine the barriers and facilitators to selecting active surveillance among patients with low-risk papillary thyroid carcinoma in China.Methods: Thirty-nine participants diagnosed with low-risk papillary thyroid carcinoma were purposively recruited between July and November 2021 for semistructured interviews; 24 of whom rejected and 15 patients chose "active surveillance" as a management approach in our sample. Inductive content analysis illustrated emerging themes. Audit trails, member checks, and thematic discussions were used to assert rigor.Results: Barriers and facilitators were classified as patient-related, disease-related, and external factors. Patient-related factors included patient's knowledge, attitudes, and emotions. Disease-related factors included the response to having cancer, the constant state of being diseased, and perceived value of the thyroid gland. External factors included the residual effects of surgery, the active surveillance protocol, and physicians' recommendations.Conclusions: Patient's acceptability of the active surveillance as a management approach are complex with many influencing factors. The public acceptance of active surveillance as a disease management approach needs to be improved, through the presentation of active surveillance as an evidence-based and optimized dynamic management strategy. Clinicians must address their patients' psychological struggles when patients choose active surveillance and patients require more attention and supportive intervention.
引用
收藏
页码:826 / 834
页数:9
相关论文
共 50 条
  • [41] Comparison of the costs of active surveillance and immediate surgery in the management of low-risk papillary microcarcinoma of the thyroid
    Oda, Hitomi
    Miyauchi, Akira
    Ito, Yasuhiro
    Sasai, Hisanori
    Masuoka, Hiroo
    Yabuta, Tomonori
    Fukushima, Mitsuhiro
    Higashiyama, Takuya
    Kihara, Minoru
    Kobayashi, Kaoru
    Miya, Akihiro
    ENDOCRINE JOURNAL, 2017, 64 (01) : 59 - 64
  • [42] Thirty years of active surveillance for low-risk thyroid cancer, lessons learned and future directions
    Smulever, Anabella
    Pitoia, Fabian
    REVIEWS IN ENDOCRINE & METABOLIC DISORDERS, 2024, 25 (01) : 65 - 78
  • [43] Active surveillance for low-risk bladder cancer
    Tiu, Albert
    Jenkins, Lawrence C.
    Soloway, Mark S.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2014, 32 (01) : 33.e7 - 33.e10
  • [44] Active surveillance for low-risk prostate cancer
    Hadjipavlou, Marios
    Promponas, John
    Madaan, Sanjeev
    JOURNAL OF CLINICAL UROLOGY, 2015, 8 (06) : 420 - 428
  • [45] Active surveillance for low-risk prostate cancer
    Bangma, Chris H.
    Bul, Meelan
    van der Kwast, Theo H.
    Pickles, Tom
    Korfage, Ida J.
    Hoeks, Caroline M.
    Steyerberg, Ewout W.
    Jenster, Guido
    Kattan, Michael W.
    Bellardita, Lara
    Carroll, Peter R.
    Denis, Louis J.
    Parker, Chris
    Roobol, Monique J.
    Emberton, Mark
    Klotz, Laurence H.
    Rannikko, Antti
    Kakehi, Yoshiyuki
    Lane, Janet A.
    Schroder, Fritz H.
    Semjonow, Axel
    Trock, Bruce J.
    Valdagni, Riccardo
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2013, 85 (03) : 295 - 302
  • [46] Active surveillance for low-risk localized prostate cancer: what do men and their partners think?
    Mallapareddi, Arun
    Ruterbusch, Julie
    Reamer, Elyse
    Eggly, Susan
    Xu, Jinping
    FAMILY PRACTICE, 2017, 34 (01) : 90 - 97
  • [47] Can Active Surveillance Management be Developed for Patients With Low-Risk Papillary Thyroid Microcarcinoma? A Preliminary Investigation in a Chinese Population
    Liu, Wen
    Cao, Weihan
    Dong, Zhizhong
    Cheng, Ruochuan
    ENDOCRINE PRACTICE, 2022, 28 (04) : 391 - 397
  • [48] Ablation techniques or active surveillance compared to surgical resection in patients with low-risk papillary thyroid cancer: a systematic review and meta-analysis
    Ledesma-Leon, Tannya
    Solis-Pazmino, Paola
    Lincango, Eddy P.
    Figueroa, Luis A.
    Ellenhorn, Joshua
    Nasseri, Yosef
    Cohen, Jason
    Romero-Arenas, Minerva
    Garcia, Cristhian
    Sanabria, Alvaro
    Rojas, Tatiana
    Torres-Roman, Junior
    Camacho, Emilia
    Vallejo, Sebastian
    Alvarado-Mafla, Benjamin
    Dream, Sophie
    James, Benjamin C.
    Ponce, Oscar J.
    Sharma, Arun
    Brito, Juan P.
    ENDOCRINE, 2024, 83 (02) : 330 - 341
  • [49] Conservative management of low-risk papillary thyroid carcinoma: a review of the active surveillance experience
    Anabella Smulever
    Fabian Pitoia
    Thyroid Research, 16
  • [50] Active Surveillance Outcomes of Patients with Low-Risk Papillary Thyroid Microcarcinoma According to Levothyroxine Treatment Status
    Yamamoto, Masashi
    Miyauchi, Akira
    Ito, Yasuhiro
    Fujishima, Makoto
    Sasaki, Takahiro
    Kudo, Takumi
    THYROID, 2023, 33 (10) : 1182 - 1189